Related Experiment Video
Updated: Mar 8, 2026

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice
Published on: August 9, 2013
Serum prealbumin and its changes over time are associated with mortality in acute kidney injury
Wenji Wang1, Yu Pan1, Xiao Tang2
1Division of Nephrology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200011, China.
Insights
Serum prealbumin levels and their changes predict mortality in acute kidney injury (AKI) patients. Monitoring prealbumin can improve 90-day mortality predictions in AKI, offering better prognostic insights.
Area of Science:
- Nephrology
- Clinical Nutrition
- Biomarkers
Background:
- Serum prealbumin is a key indicator of nutritional status and inflammation.
- Acute kidney injury (AKI) poses significant mortality risks.
- Predicting mortality in AKI patients is crucial for timely intervention.
Purpose of the Study:
- To evaluate if serum prealbumin levels and their weekly changes improve 90-day mortality prediction in AKI patients.
- To compare the predictive performance of serum prealbumin versus serum albumin for mortality.
Main Methods:
- Prospective cohort study of 340 adult AKI patients.
- Analysis of serum prealbumin levels at diagnosis and over one week.
- Utilized Cox regression models and NRI/aIDI for prediction improvement assessment.
Main Results:
- Low prealbumin (<10 mg/dL) at AKI diagnosis increased mortality risk (aHR, 2.55).
- A significant drop in prealbumin (>4 mg/dL) over a week also predicted mortality (aHR, 1.79).
- Prealbumin and its changes showed superior mortality predictability compared to albumin.
Conclusions:
- Serum prealbumin levels and their longitudinal changes are independent predictors of poor prognosis in AKI.
- Incorporating prealbumin metrics enhances the prediction of 90-day mortality in AKI patients.
- Serum prealbumin serves as a valuable surrogate marker for AKI mortality prediction.
Abstract:
Serum prealbumin is a clinically relevant indicator of nutritional status and inflammation in patients with acute kidney injury (AKI). This study aimed to determine whether serum prealbumin and its longitudinal changes over a week could improve the prediction of 90-day mortality in AKI patients. This prospective cohort study included 340 adults with AKI between 2014 and 2015. There were 94 (27.6%) patient deaths within 90 days. Serum prealbumin level <10 mg/dL at the time of AKI diagnosis was associated with a 155% increased death risk ratio (adjusted hazard ratio [HR], 2.55; 95% confidence interval [CI], 1.18 to 5.49; P = 0.02). Serum prealbumin fall >4 mg/dL was also associated with 90-day mortality in adjusted Cox regression models (HR, 1.79; 95% CI, 1.06 to 3.03; P = 0.03). Compared to serum albumin, mortality-predictability of serum prealbumin (P = 0.01) and its changes (P = 0.01) were both increased. Adding prealbumin and its changes on the conventional covariates improved the prediction of progression to 90-day mortality (NRI 0.29, P = 0.04; aIDI 0.08; P = 0.03). In conclusion, serum prealbumin, and its changes were independent predictors of worse prognosis in AKI, and could be potential surrogates to better predict 90-day mortality.
More Related Videos
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
09:02A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury I: Introduction
Serum Studies: Renal Function Tests
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury II: Pathophysiology